Why Is Macrogenics (MGNX) Stock Down 69% Today?

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

Macrogenics stock is down on Friday as MGNX investors react to clinical trial deaths and missed earnings for the first quarter of 2024.

The post Why Is Macrogenics (MGNX) Stock Down 69% Today? appeared first on InvestorPlace.

More From InvestorPlace

• The #1 AI Investment Might Be This Company You’ve Never Heard Of
• Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In.
• Legendary Investor Predicts: “Forget A.I. THIS Technology Is the Future”